Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Accumulated Expenses (2016 - 2019)

Neurocrine Biosciences filings provide 10 years of Accumulated Expenses readings, the most recent being $38.9 million for Q4 2019.

  • On a quarterly basis, Accumulated Expenses rose 42.43% to $38.9 million in Q4 2019 year-over-year; TTM through Dec 2019 was $38.9 million, a 42.43% increase, with the full-year FY2019 number at $38.9 million, up 42.43% from a year prior.
  • Accumulated Expenses hit $38.9 million in Q4 2019 for Neurocrine Biosciences, up from $27.3 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $38.9 million in Q4 2019 to a low of $7.4 million in Q4 2015.
  • Median Accumulated Expenses over the past 5 years was $17.8 million (2016), compared with a mean of $18.5 million.
  • The widest YoY moves for Accumulated Expenses: up 160.5% in 2017, down 7.46% in 2017.
  • Neurocrine Biosciences' Accumulated Expenses stood at $7.4 million in 2015, then grew by 29.91% to $9.6 million in 2016, then surged by 160.5% to $24.9 million in 2017, then increased by 9.8% to $27.3 million in 2018, then soared by 42.43% to $38.9 million in 2019.
  • The last three reported values for Accumulated Expenses were $38.9 million (Q4 2019), $27.3 million (Q4 2018), and $24.9 million (Q4 2017) per Business Quant data.